COLO B Coloplast A/S Class B

Largest shareholder and Foundation to secure Coloplast future with new holding company

Largest shareholder and Foundation to secure Coloplast future with new holding company

As part of a generational change, the largest shareholder in Coloplast A/S, Niels Peter Louis-Hansen, will establish a new holding company. The company will be co-founded with Coloplast’s second-largest shareholder, the Aage & Johanne Louis-Hansen Foundation. The holding company will enable the stable and long-term development of Coloplast. The joint holding company will own approximately 30% of the company capital and have approximately 52% of the votes in Coloplast.

”Coloplast has benefitted from a stable and long-term ownership for almost seven decades. Today’s announcement from Coloplast’s largest shareholder, Niels Peter Louis-Hansen, indicates a clear intention to create a structure that will guarantee an equally stable and long-term ownership for decades to come. Naturally, the Coloplast Board of Directors and executive leadership support this fully,” says Lars Rasmussen, Chairman of the Coloplast Board of Directors.

The new holding company will ensure that Coloplast’s two largest shareholders will continue to speak with one voice on matters related to the company. The holding company will also give Niels Peter Louis-Hansen the opportunity to create a new non-profit foundation at a later point in time through a donation of the Coloplast shares that he owns through the holding company.

Contacts

For more information regarding the new holding company or questions directed at Niels Peter Louis-Hansen:

Louise Münter







Questions directed at Coloplast:

Peter Mønster

Sr. Media Relations Manager, Corporate Communications



 

Aleksandra Dimovska

Senior Director, Investor Relations



Attachments



EN
21/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 Sep...

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.The purpose of the event is to give institutional investors and financial analysts an introductio...

Coloplast AS: 1 director

A director at Coloplast AS bought 18,450 shares at 650.500DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch